specialty centers given similar size and anatomy.
3 They argued that a requirement for pediatric-specific qualifications might impose geographic, financial, or other limitations to care that could inadvertently worsen access to HT. Proponents of the revision contended that the care needs of children and adolescents who require/receive transplantation are distinct from those of adults. 4 Though emerging literature shows that adolescent and young adult transplant recipients have the poorest survival, due in part to nonadherence, [5] [6] [7] [8] we found no peer-reviewed analyses of transplant outcomes according to whether the transplant center was specialized for care of children or adults.
In this analysis we sought to characterize pediatric (age <18 years old) HT at US centers organized primarily for adult care and to compare survival between children who received HT at adult versus pediatric centers. We hypothesized that pediatric recipients at adult centers would be older and less commonly have underlying congenital heart disease (CHD) than children transplanted at pediatric centers. We also hypothesized that children receiving HT at adult centers would have higher rates of graft loss/death beyond 1 year, presumably because adult HT centers are not organized to meet the specialized care needs of the high-risk adolescent recipient population.
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2 | MATERIAL S AND ME THODS
| Data collection and Center definition
After Institutional Review Board determination of exemption, we analyzed an OPTN Standard Transplant Analysis and Research dataset current to September 25, 2015 . The data are publicly available for research and have been previously described. 10 To identify pediatric HT recipients, we included records according to the following criteria: heart-only recipients with no prior history of organ transplantation; HT center located in the 48 contiguous We also collected the time to death, retransplantation, or loss to follow-up, as well as the occurrence of acute rejection in the first year after HT among first-year survivors. Distance from each recipient's home to their transplant center was derived using zip code-based latitude and longitude coordinates and calculating geodesic distance between coordinates.
11,12
Because there is no indicator variable that defines center type (pediatric vs adult), we conceptualized 3 separate "archetypes" of pediatric HT care in our approach to data analysis: (1) freestanding children's hospitals, (2) children's hospitals "within a hospital,"
and (3) adult specialty centers performing pediatric HT. To distinguish between these types, we utilized a data-driven approach in which we examined data for all pediatric HT performed in the United States from 1987 to 2015 and identified natural clustering of the centers based on pediatric:total HT volume ratios and minimum age of HT ( Figure 1 ). We identified a cluster of centers with pediatric:adult HT volume >0.7, which were designated as only possessing pediatric specialty care. We also found a cluster of centers that transplanted only patients above 8 years old
and additionally had a low pediatric:adult HT volume of <0.05.
Therefore, we designated these centers as adult-specialty-only centers. The remaining group of centers that met neither adult nor pediatric criteria were labeled as "indeterminate" because we are not able to distinguish with certainty whether patients at these centers received adult-only, or pediatric specialty care
at a "children's hospital within a hospital." To reduce the risk of misclassification, we excluded these patients from analysis of outcomes and the selection of matched controls. Using a standard matching caliper of one-fifth the standard deviation of the logit of the propensity scores, we used nearest neighbor matching without replacement to match each child who received HT at an adult center to 2 children who received HT at a pediatric center.
One to 2 matching was chosen to improve precision of estimates without a commensurate increase in bias. 13 All patients <9 years old in the pediatric HT center group were excluded from matching since there were no such recipients in the adult HT center group. Covariate matching balance was assessed by graphical comparison of propensity score histograms between matched groups and by assessment of the standardized mean bias (>0.2 was considered significant).
| Statistical analysis
Continuous data are presented as median (interquartile range) and categorical data as count (%). Pretransplant characteristics and nonsurvival outcomes (geolocation data, insurance, and rejection in the first year) were compared across groups using Fisher exact test for binary data, χ 2 test for categorical data and Wilcoxon rank-sum test for continuous data. Survival curves for freedom from graft failure between groups were estimated using the Kaplan-Meier method.
Survival time was calculated from time of transplant until graft failure (defined as patient death or retransplantation). Patients who did not experience the endpoint were censored at time of last available follow-up. The proportional hazards assumption was assessed visually with log-log survival plots. The effect of center type on survival was summarized using hazard ratios (HRs) obtained by fitting a uni-
variate Cox proportional hazard model with robust standard errors clustered within matched groups. Missing outcome data included geolocation (0% adult vs 4% pediatric, P = .30) and acute rejection in the first year (8% adult vs 7% pediatric, P = .818). Since proportions of missingness were low, all missing outcome data were analyzed using complete-case analysis. Data were analyzed using STATA 13.1 (StataCorp LP, College Station, TX). All analyses considered a 2-sided P value < .05 as statistically significant.
| Sensitivity analyses
To provide external validity to our classification scheme, we repeated the analysis with the OPTN bylaw-stipulated pediatricspecific provider qualifications (≥8 HT in patients <18 years old, with ≥4 HT recipients <6 years old or <25 kg) applied to center-level data.
This has been performed in prior analyses from OPTN. 1, 14 We compared this classification scheme to our primary classification scheme by calculating agreement and Cohen's κ. To understand the potential effects of missing data, we repeated the analysis with imputation of missing crossmatch data as positive to observe for any changes in results. To understand the potential effects of pediatric transition to adult-specialty care, we repeated the survival analysis but censored observations at age 26, thus "ignoring" patient outcomes after they were likely to have transitioned to adult specialty care. Characteristics of the groups prior to matching are shown in Table 1 . Patients transplanted at adult-specialty centers were older (16 vs 2 years, P < .001), more commonly male (71% vs 54%, P = .003), and more commonly bridged to transplant with VAD (36% vs 12%, P < .001). They were less likely to be status 1A (73% vs 82%, P = .012), admitted to the hospital at time of HT (14% vs 32%, P < .001), on ventilator at HT (5% vs 20%, P = .001), or have underlying CHD (10% vs 48% P < .001).
| RE SULTS

| Center classification and patient characteristics
| Propensity-matched outcomes
Propensity score matching was successful in achieving a 1:2 match for all but 3 children transplanted at an adult center. In these instances, a 1:1 match was utilized. After matching, the proportion of patients that underwent imputation of missing VAD data was the same between groups (16% adult vs 18% pediatric, P = .672); however, more patients had imputed crossmatch data in the adult-specialty center group (19% vs 8%, P = .031). Comparison of group characteristics after matching showed no significant differences (Table 1) We observed no significant difference in graft survival between the matched groups (hazard ratio [HR] 0.73, P = .160, Figure 2 ). Of the patients surviving to 1 year, the proportion that experienced acute rejection in the first year post-HT was not different between the matched groups (33% adult vs 32%, P = .824).
Among the matched cohorts, the adult-specialty center patients lived closer to their transplant center than pediatric-specialty center controls (31 vs 45 miles, P = .012). Though there was no significant difference in the proportion of patients with public insurance between adult and pediatric-specialty center groups (43% vs 41%, P = .871), there was a trend toward fewer recipients at adult-specialty centers outside of their home state (15% vs 25%, P = .082).
| Sensitivity analyses
In sensitivity analysis of our main outcome in which we applied OPTN bylaw pediatric qualification criteria to centers, we identified 99 children from 2000 to 2015 transplanted at 38 centers that never met OPTN volume criteria to qualify as a pediatricspecialty center. We noted that 5 of these centers were named children's hospitals, indicating a likely misclassification. Nonetheless, there was overall good agreement between this classification scheme and the criteria used in our primary analysis (89% agreement, Cohen's κ 0.77, P < .001). After propensity matching to 191 patients from centers that did meet OPTN pediatric-specialty criteria, we found no difference in graft survival between groups (HR: 1.08, P = .732, S1; Figure S1 ). We also performed sensitivity analysis on the effect of missing data in which we imputed crossmatch data as positive (rather than negative) and found no difference in graft survival (HR 0.85, P = .523, data not shown). Finally, we found no change in result in a sensitivity analysis of graft survival in which patients were censored at age 26 years to account for likely transition of pediatric patients to adult-specialty care (HR 0.71, P = .155, data not shown).
| D ISCUSS I ON
We provide novel data on the characteristics and outcomes of patients <18 years old who received HT at US centers organized primarily for adult-specialty care. We utilized a data-driven approach to segment transplant centers into adult and pediatric-specialty care centers in order to identify a cohort of pediatric patients who underwent HT at adult-specialty centers. Children who received HT at adult centers were older (not surprisingly, as clustering on the minimum age of HT was part of our center criteria definition), and less often had CHD. Compared to propensity-matched controls from pediatric-specialty centers, we found no difference in the risk of graft loss among patients transplanted at adult-specialty centers. This suggests that select adolescent patients without CHD may achieve similar midterm graft survival results regardless of care setting.
In a recent related analysis, Rana et al analyzed OPTN data from 2002 to 2014 to describe waitlist and post-HT mortality at low-volume pediatric transplant centers, including adult-specialty centers. 15 Although their methodology for designating centers as primarily pediatric or adult-specialty was not described, they also found no difference in post-HT recipient survival between center types. Of note, they also reported that adult-specialty centers had increased risk of waitlist mortality relative to high-volume pediatricspecific centers. This is an important point that we did not consider in our analysis, as we only aimed to examine differences in post HT survival between adult-and pediatric-specialty care.
Chronic disease care in pediatrics tends to be more familycentered and developmentally oriented, whereas for adults it tends to be more self-directed. 16, 17 Thus, we assumed that children transplanted at adult centers would receive less support and fare less well. This sentiment was also shared commonly during the public comment prior to approval of these bylaw changes, 3,4 and has been reported as a component of patient and provider fears about transition from pediatric to adult care environments. [17] [18] [19] One possibility to explain the lack of difference in survival is that neither the prevalent pediatric nor adult care models adequately impact behavior to affect decreased rates of death and graft failure among adolescents and young adults. This may be reflected in the fact that both adolescents and adults under age 25 (ie, the "emerging adult" population) have the highest risk of graft failure after solid organ transplantation. 5, 6, 8 Age has been shown to be an independent predictor of graft failure across various solid organ transplant recipient groups. 7 Nonadherence has been most commonly thought to drive the increased risk in this age group as evidenced by data showing that emerging adult recipients have high rates of nonadherence to medications and recommended follow-up after solid organ transplantation. 9, 20, 21 Effective interventions to overcome nonadherence in adolescents with chronic disease have been reported, including clustering of multiple appointments; employment of a curious, nonjudgmental approach by providers in situations of nonadherence;
and education. 22 Emerging data also support the benefits of formal transition programs for children with chronic medical conditions.
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During public comment, concern was expressed that the bylaw revisions could potentially limit access to transplantation either through geography or the patient's medical condition. In our analysis, pediatric HT from ECMO in adult centers was rare (n = 2, 3%); however, VAD use was more common (n = 29, 36%).
Further examination of waitlist outcomes is required to evaluate the potential impact of the emergency exception pathway.
| Limitations
Our study has several limitations. The OPTN database does not contain data on provider qualifications, and some centers possess both adult and pediatric specialties under 1 umbrella center designation (ie, children's hospital within an adult hospital model). We did not include these centers in our analysis because the potential for misclassification as primarily organized around adult or pediatric care was high. To further address the possibility of misclassification in center designation, we repeated the analysis by applying OPTN pediatric provider-level qualification data to centers and found similar results. We chose not to perform the primary analysis based on the OPTN classification criteria because it obviously misclassified named children's hospitals as adultspecialty centers in some instances. However, the high overall agreement between centers identified by our primary methodology and this sensitivity analysis suggest that our findings are robust to different classification techniques.
Our analysis is also potentially limited by selection/indication bias. Though propensity score matching allowed us to diminish this limitation, we were unable to control for unrecorded potential confounders, such as personal or financial factors that influenced the location or quality of care. Missing data were minimal, and the findings were robust to different imputation techniques.
We could not determine the site of follow-up care >6 months after HT, limiting our ability to observe the effect of transitions to adult-or pediatric-specialty care on survival. We expect that many patients at pediatric-specialty centers would have transferred to adult-specialty center care 5-10 years posttransplant (when median age would be 21-26 years old), potentially limiting the interpretation of our survival analysis after this time period. To explore this, we repeated the survival analysis and censored patients at age 26 years to "ignore" outcomes after presumed transition to adult care. Our conclusions were unchanged, suggesting that transition of pediatric-specialty care patients to adult-specialty care would not significantly impact our results. Finally, interpretation of data from the unmatched cohorts must consider that age was a factor in center designation. Thus, our observed differences between the unmatched groups (such as age, VAD use, etc.) could stem primarily from our center-designation methodology, rather than an accurate reflection of pediatric HT at adult-specialty centers in the United
States.
| Conclusion
In a multicenter cohort of predominately adolescent patients without congenital heart disease that underwent primary pediatric HT at centers organized primarily for adult care, we found similar midterm graft survival compared to pediatric-specialty care centers.
Adult-specialty center recipients lived closer to their transplant center and may receive in-state HT more commonly than matched pediatric-specialty center recipients, potentially indicating that proximity to care may impact decision-making around center choice for some patients. Focus on the development of care models that demonstrably improve adherence, regardless of post HT care setting, may be of greatest benefit to improving posttransplant survival among this high-risk population of emerging adults.
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